Henry Szechtman, PhD - Publications

Affiliations: 
1980- Psychiatry and Behavioural Neurosciences McMaster University, Hamilton, ON, Canada 
Area:
security motivation, obsessive-compulsive disorder (OCD), dopamine
Website:
http://szechtman.com

160 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Johnson EF, Szechtman H. A dose-response study of separate and combined effects of the serotonin agonist 8-OH-DPAT and the dopamine agonist quinpirole on locomotor sensitization, cross-sensitization, and conditioned activity. Behavioural Pharmacology. PMID 26871406 DOI: 10.1097/FBP.0000000000000219  1
2015 Tucci MC, Dvorkin-Gheva A, Johnson E, Wong M, Szechtman H. 5-HT2A/C receptors do not mediate the attenuation of compulsive checking by mCPP in the quinpirole sensitization rat model of obsessive-compulsive disorder (OCD). Behavioural Brain Research. 279: 211-7. PMID 25449840 DOI: 10.1016/j.bbr.2014.11.017  1
2015 Ballester González J, Dvorkin-Gheva A, Silva C, Foster JA, Szechtman H. Nucleus accumbens core and pathogenesis of compulsive checking. Behavioural Pharmacology. 26: 200-16. PMID 25426580 DOI: 10.1097/FBP.0000000000000112  1
2014 Tucci MC, Dvorkin-Gheva A, Johnson E, Cheon P, Taji L, Agarwal A, Foster J, Szechtman H. Performance of compulsive behavior in rats is not a unitary phenomenon - validation of separate functional components in compulsive checking behavior. The European Journal of Neuroscience. 40: 2971-9. PMID 24935528 DOI: 10.1111/ejn.12652  1
2014 Tucci MC, Dvorkin-Gheva A, Sharma R, Taji L, Cheon P, Peel J, Kirk A, Szechtman H. Separate mechanisms for development and performance of compulsive checking in the quinpirole sensitization rat model of obsessive-compulsive disorder (OCD). Psychopharmacology. 231: 3707-18. PMID 24682503 DOI: 10.1007/s00213-014-3505-6  1
2014 Hinds AL, Woody EZ, Schmidt LA, Van Ameringen M, Szechtman H. In the wake of a possible mistake: Security motivation, checking behavior, and OCD Journal of Behavior Therapy and Experimental Psychiatry. DOI: 10.1016/j.jbtep.2015.03.016  1
2013 Tucci MC, Dvorkin-Gheva A, Graham D, Amodeo S, Cheon P, Kirk A, Peel J, Taji L, Szechtman H. Effects of the serotonergic agonist mCPP on male rats in the quinpirole sensitization model of obsessive-compulsive disorder (OCD). Psychopharmacology. 227: 277-85. PMID 23354534 DOI: 10.1007/s00213-013-2976-1  1
2013 Alkhatib AH, Dvorkin-Gheva A, Szechtman H. Quinpirole and 8-OH-DPAT induce compulsive checking behavior in male rats by acting on different functional parts of an OCD neurocircuit. Behavioural Pharmacology. 24: 65-73. PMID 23249525 DOI: 10.1097/FBP.0b013e32835d5b7a  1
2013 Aksenov V, Long J, Liu J, Szechtman H, Khanna P, Matravadia S, Rollo CD. A complex dietary supplement augments spatial learning, brain mass, and mitochondrial electron transport chain activity in aging mice. Age (Dordrecht, Netherlands). 35: 23-33. PMID 22120182 DOI: 10.1007/s11357-011-9325-2  1
2013 Woody EZ, Szechtman H. A biological security motivation system for potential threats: Are there implications for policy-making? Frontiers in Human Neuroscience. DOI: 10.3389/fnhum.2013.00556  1
2012 Bachus SE, Pellis SM, Rowland NE, Stellar JR, Szechtman H. Introduction to Quo Vadis behavioral neuroscience: a Festschrift for Philip Teitelbaum. Behavioural Brain Research. 231: 231-2. PMID 22521409 DOI: 10.1016/j.bbr.2012.04.008  1
2012 Hinds AL, Woody EZ, van Ameringen M, Schmidt LA, Szechtman H. When too much is not enough: Obsessive-compulsive disorder as a pathology of stopping, rather than starting Plos One. 7. PMID 22291994 DOI: 10.1371/journal.pone.0030586  1
2011 Zor R, Szechtman H, Hermesh H, Fineberg NA, Eilam D. Manifestation of incompleteness in obsessive-compulsive disorder (OCD) as reduced functionality and extended activity beyond task completion. Plos One. 6: e25217. PMID 21966460 DOI: 10.1371/journal.pone.0025217  1
2011 Woody EZ, Szechtman H. Adaptation to potential threat: The evolution, neurobiology, and psychopathology of the security motivation system Neuroscience and Biobehavioral Reviews. 35: 1019-1033. PMID 20727910 DOI: 10.1016/j.neubiorev.2010.08.003  1
2010 Dvorkin A, Silva C, McMurran T, Bisnaire L, Foster J, Szechtman H. Features of compulsive checking behavior mediated by nucleus accumbens and orbital frontal cortex. The European Journal of Neuroscience. 32: 1552-63. PMID 20731708 DOI: 10.1111/j.1460-9568.2010.07398.x  1
2010 Hinds AL, Woody EZ, Drandic A, Schmidt LA, Van Ameringen M, Coroneos M, Szechtman H. The psychology of potential threat: Properties of the security motivation system Biological Psychology. 85: 331-337. PMID 20723575 DOI: 10.1016/j.biopsycho.2010.08.003  1
2010 Galea V, Woody EZ, Szechtman H, Pierrynowski MR. Motion in response to the hypnotic suggestion of arm rigidity: a window on underlying mechanisms. The International Journal of Clinical and Experimental Hypnosis. 58: 251-68. PMID 20509067 DOI: 10.1080/00207141003760561  1
2010 Dvorkin A, Szechtman H, Golani I. Knots: attractive places with high path tortuosity in mouse open field exploration. Plos Computational Biology. 6: e1000638. PMID 20090825 DOI: 10.1371/journal.pcbi.1000638  1
2009 Zor R, Keren H, Hermesh H, Szechtman H, Mort J, Eilam D. Obsessive-compulsive disorder: a disorder of pessimal (non-functional) motor behavior. Acta Psychiatrica Scandinavica. 120: 288-98. PMID 19291081 DOI: 10.1111/j.1600-0447.2009.01370.x  1
2009 Zor R, Hermesh H, Szechtman H, Eilam D. Turning order into chaos through repetition and addition of elementary acts in obsessive-compulsive disorder (OCD). The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 10: 480-7. PMID 17853263 DOI: 10.1080/15622970701416539  1
2009 Szechtman H, Eilam D. Psychiatric Models The Behavior of the Laboratory Rat: a Handbook With Tests. DOI: 10.1093/acprof:oso/9780195162851.003.0043  1
2008 Beerepoot P, Lam V, Luu A, Tsoi B, Siebert D, Szechtman H. Effects of salvinorin A on locomotor sensitization to D2/D3 dopamine agonist quinpirole. Neuroscience Letters. 446: 101-4. PMID 18824069 DOI: 10.1016/j.neulet.2008.09.035  1
2008 Culver KE, Szechtman H, Levant B. Altered dopamine D2-like receptor binding in rats with behavioral sensitization to quinpirole: effects of pre-treatment with Ro 41-1049. European Journal of Pharmacology. 592: 67-72. PMID 18644362 DOI: 10.1016/j.ejphar.2008.06.101  1
2008 Dvorkin A, Culver KE, Waxman D, Szechtman H, Kolb B. Effects of hypophysectomy on compulsive checking and cortical dendrites in an animal model of obsessive-compulsive disorder. Behavioural Pharmacology. 19: 271-83. PMID 18622174 DOI: 10.1097/FBP.0b013e3283095223  1
2008 Chaudhry AM, Marsh-Rollo SE, Aksenov V, Rollo CD, Szechtman H. Modifier selection by transgenes: The case of growth hormone transgenesis and hyperactive circling mice Evolutionary Biology. 35: 267-286. DOI: 10.1007/s11692-008-9036-5  1
2007 Perreault ML, Seeman P, Szechtman H. Kappa-opioid receptor stimulation quickens pathogenesis of compulsive checking in the quinpirole sensitization model of obsessive-compulsive disorder (OCD). Behavioral Neuroscience. 121: 976-91. PMID 17907829 DOI: 10.1037/0735-7044.121.5.976  1
2007 Perreault ML, Graham D, Scattolon S, Wang Y, Szechtman H, Foster JA. Cotreatment with the kappa opioid agonist U69593 enhances locomotor sensitization to the D2/D3 dopamine agonist quinpirole and alters dopamine D2 receptor and prodynorphin mRNA expression in rats. Psychopharmacology. 194: 485-96. PMID 17619861 DOI: 10.1007/s00213-007-0855-3  1
2006 Szechtman H, Woody EZ. Obsessive-compulsive disorder as a disturbance of security motivation: Constraints on comorbidity Neurotoxicity Research. 10: 103-112. PMID 17062372 DOI: 10.1007/BF03033239  1
2006 Seeman P, Schwarz J, Chen JF, Szechtman H, Perreault M, McKnight GS, Roder JC, Quirion R, Boksa P, Srivastava LK, Yanai K, Weinshenker D, Sumiyoshi T. Psychosis pathways converge via D2high dopamine receptors. Synapse (New York, N.Y.). 60: 319-46. PMID 16786561 DOI: 10.1002/syn.20303  1
2006 Dvorkin A, Culver KE, Szechtman H. Differential effects of clorgyline on sensitization to quinpirole in rats tested in small and large environments. Psychopharmacology. 186: 534-43. PMID 16758240 DOI: 10.1007/s00213-006-0377-4  1
2006 Varghese AK, Verdú EF, Bercik P, Khan WI, Blennerhassett PA, Szechtman H, Collins SM. Antidepressants attenuate increased susceptibility to colitis in a murine model of depression. Gastroenterology. 130: 1743-53. PMID 16697738 DOI: 10.1053/j.gastro.2006.02.007  1
2006 Dvorkin A, Perreault ML, Szechtman H. Development and temporal organization of compulsive checking induced by repeated injections of the dopamine agonist quinpirole in an animal model of obsessive-compulsive disorder. Behavioural Brain Research. 169: 303-11. PMID 16524632 DOI: 10.1016/j.bbr.2006.01.024  1
2006 Eilam D, Zor R, Szechtman H, Hermesh H. Rituals, stereotypy and compulsive behavior in animals and humans. Neuroscience and Biobehavioral Reviews. 30: 456-71. PMID 16253329 DOI: 10.1016/j.neubiorev.2005.08.003  1
2006 Perreault ML, Graham D, Bisnaire L, Simms J, Hayton S, Szechtman H. Kappa-opioid agonist U69593 potentiates locomotor sensitization to the D2/D3 agonist quinpirole: pre- and postsynaptic mechanisms. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 1967-81. PMID 16237381 DOI: 10.1038/sj.npp.1300938  1
2006 Anderson KK, Ballok DA, Prasad N, Szechtman H, Sakic B. Impaired response to amphetamine and neuronal degeneration in the nucleus accumbens of autoimmune MRL-lpr mice. Behavioural Brain Research. 166: 32-8. PMID 16183144 DOI: 10.1016/j.bbr.2005.07.030  1
2006 Woody EZ, Szechtman H. Uncertainty and rituals Behavioral and Brain Sciences. 29: 634-635. DOI: 10.1017/S0140525X06009563  1
2005 Sakic B, Kirkham DL, Ballok DA, Mwanjewe J, Fearon IM, Macri J, Yu G, Sidor MM, Denburg JA, Szechtman H, Lau J, Ball AK, Doering LC. Proliferating brain cells are a target of neurotoxic CSF in systemic autoimmune disease. Journal of Neuroimmunology. 169: 68-85. PMID 16198428 DOI: 10.1016/j.jneuroim.2005.08.010  1
2005 Eilam D, Szechtman H. Psychostimulant-induced behavior as an animal model of obsessive-compulsive disorder: an ethological approach to the form of compulsive rituals. Cns Spectrums. 10: 191-202. PMID 15744221  1
2005 Woody EZ, Lewis V, Snider L, Grant H, Kamath M, Szechtman H. Induction of compulsive-like washing by blocking the feeling of knowing: An experimental test of the security-motivation hypothesis of Obsessive-Compulsive Disorder Behavioral and Brain Functions. 1. DOI: 10.1186/1744-9081-1-11  1
2005 Woody EZ, Szechtman H. Motivation, time course, and heterogeneity in obsessive-compulsive disorder: Response to Taylor, McKay, and Abramowitz (2005) Psychological Review. 112: 658-661. DOI: 10.1037/0033-295X.112.3.658  1
2004 Van Ameringen M, Mancini C, Szechtman H, Nahmias C, Oakman JM, Hall GB, Pipe B, Farvolden P. A PET provocation study of generalized social phobia. Psychiatry Research. 132: 13-8. PMID 15546699 DOI: 10.1016/j.pscychresns.2004.07.005  1
2004 Szechtman H. Context gives meaning. Commentary on Badiani and Robinson drug-induced neurobehavioral plasticity: the role of environmental context. Behavioural Pharmacology. 15: 381-5. PMID 15343064  1
2004 Hall GB, Witelson SF, Szechtman H, Nahmias C. Sex differences in functional activation patterns revealed by increased emotion processing demands. Neuroreport. 15: 219-23. PMID 15076740 DOI: 10.1097/00001756-200402090-00001  1
2004 Lomanowska A, Gormley S, Szechtman H. Presynaptic stimulation and development of locomotor sensitization to the dopamine agonist quinpirole. Pharmacology, Biochemistry, and Behavior. 77: 617-22. PMID 15006474 DOI: 10.1016/j.pbb.2003.12.018  1
2004 Szechtman H, Woody E. Obsessive-compulsive disorder as a disturbance of security motivation. Psychological Review. 111: 111-27. PMID 14756589 DOI: 10.1037/0033-295X.111.1.111  1
2004 Culver KE, Szechtman H. Hypophysectomy does not block sensitization to the dopamine agonist quinpirole or its modulation by the MAOI clorgyline. Hormones and Behavior. 45: 23-30. PMID 14733888 DOI: 10.1016/j.yhbeh.2003.07.004  1
2003 Woody EZ, Szechtman H. How can brain activity and hypnosis inform each other? The International Journal of Clinical and Experimental Hypnosis. 51: 232-55. PMID 12934842 DOI: 10.1076/iceh.51.3.232.15521  1
2003 Hall GB, Szechtman H, Nahmias C. Enhanced salience and emotion recognition in Autism: a PET study. The American Journal of Psychiatry. 160: 1439-41. PMID 12900306 DOI: 10.1176/appi.ajp.160.8.1439  1
2003 Gabriele J, Culver K, Sharma S, Zhang B, Szechtman H, Mishra R. Asymmetric modulation of a catecholamine-regulated protein in the rat brain, following quinpirole administration. Synapse (New York, N.Y.). 49: 261-9. PMID 12827645 DOI: 10.1002/syn.10224  1
2003 Culver KE, Szechtman H. Clorgyline-induced switch from locomotion to mouthing in sensitization to the dopamine D2/D3 agonist quinpirole in rats: role of sigma and imidazoline I2 receptors. Psychopharmacology. 167: 211-8. PMID 12652347 DOI: 10.1007/s00213-003-1408-z  1
2003 Ballok DA, Szechtman H, Sakic B. Taste responsiveness and diet preference in autoimmune MRL mice. Behavioural Brain Research. 140: 119-30. PMID 12644285 DOI: 10.1016/S0166-4328(02)00276-0  1
2002 Culver KE, Rosenfeld JM, Szechtman H. Monoamine oxidase inhibitor-induced blockade of locomotor sensitization to quinpirole: role of striatal dopamine uptake inhibition. Neuropharmacology. 43: 385-93. PMID 12243768 DOI: 10.1016/S0028-3908(02)00128-4  1
2002 Sakic B, Lacosta S, Denburg JA, Szechtman H. Altered neurotransmission in brains of autoimmune mice: pharmacological and neurochemical evidence. Journal of Neuroimmunology. 129: 84-96. PMID 12161024 DOI: 10.1016/S0165-5728(02)00171-6  1
2002 Szumlinski KK, Szechtman H. D2 receptor blockade in the dorsal raphe increases quinpirole-induced locomotor excitation. Neuroreport. 13: 563-6. PMID 11973446  1
2002 Shaldubina A, Einat H, Szechtman H, Shimon H, Belmaker RH. Preliminary evaluation of oral anticonvulsant treatment in the quinpirole model of bipolar disorder. Journal of Neural Transmission (Vienna, Austria : 1996). 109: 433-40. PMID 11956963 DOI: 10.1007/s007020200035  1
2002 Tizabi Y, Louis VA, Taylor CT, Waxman D, Culver KE, Szechtman H. Effect of nicotine on quinpirole-induced checking behavior in rats: implications for obsessive-compulsive disorder. Biological Psychiatry. 51: 164-71. PMID 11822995 DOI: 10.1016/S0006-3223(01)01207-0  1
2002 Woody E, Szechtman H. The sensation of making sense: Motivational properties of the "fringe" Psyche. 8.  1
2001 Ben-Pazi A, Szechtman H, Eilam D. The morphogenesis of motor rituals in rats treated chronically with the dopamine agonist quinpirole. Behavioral Neuroscience. 115: 1301-17. PMID 11770061 DOI: 10.1037//0735-7044.115.6.1301  1
2001 Maric D, Millward JM, Ballok DA, Szechtman H, Denburg JA, Barker JL, Sakic B. Neurotoxic properties of cerebrospinal fluid from behaviorally impaired autoimmune mice. Brain Research. 920: 183-93. PMID 11716824 DOI: 10.1016/S0006-8993(01)03060-8  1
2001 Szechtman H, Eckert MJ, Tse WS, Boersma JT, Bonura CA, McClelland JZ, Culver KE, Eilam D. Compulsive checking behavior of quinpirole-sensitized rats as an animal model of Obsessive-Compulsive Disorder(OCD): form and control. Bmc Neuroscience. 2: 4. PMID 11316464 DOI: 10.1186/1471-2202-2-4  1
2001 Sakić B, Gauldie J, Denburg JA, Szechtman H. Behavioral effects of infection with IL-6 adenovector. Brain, Behavior, and Immunity. 15: 25-42. PMID 11259078 DOI: 10.1006/brbi.1999.0576  1
2001 Denburg JA, Sakic B, Szechtman H, Denburg SD. Lupus as a model of neuroimmune interactions Neuroimmune Biology. 1: 379-386. DOI: 10.1016/S1567-7443(01)80034-X  1
2000 Szumlinski KK, Goodwill AM, Szechtman H. Locomotor sensitization to quinpirole in rats: effects of drug abstinence and sex. Psychopharmacology. 152: 304-11. PMID 11105941 DOI: 10.1007/s002130000538  1
2000 Sakic B, Kolb B, Whishaw IQ, Gorny G, Szechtman H, Denburg JA. Immunosuppression prevents neuronal atrophy in lupus-prone mice: evidence for brain damage induced by autoimmune disease? Journal of Neuroimmunology. 111: 93-101. PMID 11063826 DOI: 10.1016/S0165-5728(00)00364-7  1
2000 Culver KE, Rosenfeld JM, Szechtman H. A switch mechanism between locomotion and mouthing implicated in sensitization to quinpirole in rats. Psychopharmacology. 151: 202-10. PMID 10972466  1
2000 Sakic B, Maric I, Koeberle PD, Millward JM, Szechtman H, Maric D, Denburg JA. Increased TUNEL staining in brains of autoimmune Fas-deficient mice. Journal of Neuroimmunology. 104: 147-54. PMID 10713354 DOI: 10.1016/S0165-5728(99)00277-5  1
2000 Woody E, Szechtman H. Hypnotic hallucinations: Towards a biology of epistemology Contemporary Hypnosis. 17: 4-14.  1
2000 Woody E, Szechtman H. Hypnotic hallucinations and yedasentience Contemporary Hypnosis. 17: 26-31.  1
1999 Szechtman H, Culver K, Eilam D. Role of dopamine systems in obsessive-compulsive disorder (OCD): implications from a novel psychostimulant-induced animal model. Polish Journal of Pharmacology. 51: 55-61. PMID 10389145  1
1999 Sakić B, Laflamme N, Crnic LS, Szechtman H, Denburg JA, Rivest S. Reduced corticotropin-releasing factor and enhanced vasopressin gene expression in brains of mice with autoimmunity-induced behavioral dysfunction. Journal of Neuroimmunology. 96: 80-91. PMID 10227427 DOI: 10.1016/S0165-5728(99)00021-1  1
1999 Szechtman H, Culver K, Eilam D. Role of dopami ne systems in obsessive-compulsive disorder (ocd): implications from a novel psychosti mulant-i nduced animal model Pharmacological Reports. 51: 55-61.  1
1998 Szechtman H, Sulis W, Eilam D. Quinpirole induces compulsive checking behavior in rats: a potential animal model of obsessive-compulsive disorder (OCD). Behavioral Neuroscience. 112: 1475-85. PMID 9926830 DOI: 10.1037/0735-7044.112.6.1475  1
1998 Sakić B, Szechtman H, Denburg JA, Gorny G, Kolb B, Whishaw IQ. Progressive atrophy of pyramidal neuron dendrites in autoimmune MRL-lpr mice. Journal of Neuroimmunology. 87: 162-70. PMID 9670858 DOI: 10.1016/S0165-5728(98)00085-X  1
1998 Coscina DV, Currie PJ, Szechtman H. Association of altered whole-body metabolism with locomotor sensitization induced by quinpirole. Physiology & Behavior. 63: 755-61. PMID 9617996 DOI: 10.1016/S0031-9384(97)00531-3  1
1998 Sullivan RM, Talangbayan H, Einat H, Szechtman H. Effects of quinpirole on central dopamine systems in sensitized and non-sensitized rats. Neuroscience. 83: 781-9. PMID 9483561 DOI: 10.1016/S0306-4522(97)00412-0  1
1998 Szechtman H, Woody E, Bowers KS, Nahmias C. Where the imaginal appears real: a positron emission tomography study of auditory hallucinations. Proceedings of the National Academy of Sciences of the United States of America. 95: 1956-60. PMID 9465124 DOI: 10.1073/pnas.95.4.1956  1
1997 Culver KE, Szechtman H. Monoamine oxidase inhibitor sensitive site implicated in sensitization to quinpirole. European Journal of Pharmacology. 339: 109-11. PMID 9473123 DOI: 10.1016/S0014-2999(97)01386-1  1
1997 Szumlinski KK, Allan M, Talangbayan H, Tracey A, Szechtman H. Locomotor sensitization to quinpirole: environment-modulated increase in efficacy and context-dependent increase in potency. Psychopharmacology. 134: 193-200. PMID 9399384 DOI: 10.1007/s002130050442  1
1997 Sakić B, Szechtman H, Braciak T, Richards C, Gauldie J, Denburg JA. Reduced preference for sucrose in autoimmune mice: a possible role of interleukin-6. Brain Research Bulletin. 44: 155-65. PMID 9292205 DOI: 10.1016/S0361-9230(97)00107-X  1
1997 Brey RL, Sakic B, Szechtman H, Denburg JA. Animal models for nervous system disease in systemic lupus erythematosus. Annals of the New York Academy of Sciences. 823: 97-106. PMID 9292036 DOI: 10.1111/j.1749-6632.1997.tb48382.x  1
1997 Sakić B, Szechtman H, Denburg JA. Neurobehavioral alterations in autoimmune mice. Neuroscience and Biobehavioral Reviews. 21: 327-40. PMID 9168268 DOI: 10.1016/S0149-7634(96)00018-8  1
1997 Farrell M, Sakić B, Szechtman H, Denburg JA. Effect of cyclophosphamide on leukocytic infiltration in the brain of MRL/lpr mice. Lupus. 6: 268-74. PMID 9104735  1
1997 Szechtman H, Sakić B, Denburg JA. Behaviour of MRL mice: an animal model of disturbed behaviour in systemic autoimmune disease. Lupus. 6: 223-9. PMID 9104727  1
1997 MacFarlane JG, List SJ, Moldofsky H, Firnau G, Chen JJ, Szechtman H, Garnett S, Nahmias C. Dopamine D2 receptors quantified in vivo in human narcolepsy. Biological Psychiatry. 41: 305-10. PMID 9024953 DOI: 10.1016/S0006-3223(96)00003-0  1
1996 Sakić B, Denburg JA, Denburg SD, Szechtman H. Blunted sensitivity to sucrose in autoimmune MRL-lpr mice: a curve-shift study. Brain Research Bulletin. 41: 305-11. PMID 8924042 DOI: 10.1016/S0361-9230(96)00190-6  1
1996 Einat H, Einat D, Allan M, Talangbayan H, Tsafnat T, Szechtman H. Associational and nonassociational mechanisms in locomotor sensitization to the dopamine agonist quinpirole. Psychopharmacology. 127: 95-101. PMID 8888373  1
1996 Sakić B, Szechtman H, Stead RH, Denburg JA. Joint pathology and behavioral performance in autoimmune MRL-lpr Mice. Physiology & Behavior. 60: 901-5. PMID 8873267 DOI: 10.1016/S0031-9384(96)00065-0  1
1995 Sakić B, Szechtman H, Denburg SD, Denburg JA. Immunosuppressive treatment prevents behavioral deficit in autoimmune MRL-lpr mice. Physiology & Behavior. 58: 797-802. PMID 8559794 DOI: 10.1016/0031-9384(95)00135-6  1
1995 Denburg JA, Denburg SD, Carbotte RM, Sakić B, Szechtman H. Nervous system lupus: pathogenesis and rationale for therapy. Scandinavian Journal of Rheumatology. 24: 263-73. PMID 8533039 DOI: 10.3109/03009749509095161  1
1995 Einat H, Szechtman H. Perseveration without hyperlocomotion in a spontaneous alternation task in rats sensitized to the dopamine agonist quinpirole. Physiology & Behavior. 57: 55-9. PMID 7878126 DOI: 10.1016/0031-9384(94)00209-N  1
1995 Sullivan RM, Szechtman H. Asymmetrical influence of mesocortical dopamine depletion on stress ulcer development and subcortical dopamine systems in rats: implications for psychopathology. Neuroscience. 65: 757-66. PMID 7609874 DOI: 10.1016/0306-4522(94)00531-9  1
1995 Goldschmidt B, Denburg JA, Cabral De Almeida JC, Denburg SD, De Oliveira VL, Carbotte RM, Sakic B, Szechtman H. Visualization of nucleolar organizer regions in sloths (Bradypus variegatus and Scaeopus torquatus) Revista Brasileira De Genetica. 18: 111-113.  1
1994 Sullivan RM, Fraser A, Szechtman H. Asymmetrical orientation to edges of an openfield: modulation by striatal dopamine and relationship to motor asymmetries in the rat. Brain Research. 637: 114-8. PMID 8180788 DOI: 10.1016/0006-8993(94)91223-8  1
1994 Sullivan RM, Szechtman H. Left/right nigrostriatal asymmetry in susceptibility to neurotoxic dopamine depletion with 6-hydroxydopamine in rats. Neuroscience Letters. 170: 83-6. PMID 8041518 DOI: 10.1016/0304-3940(94)90244-5  1
1994 Sakić B, Szechtman H, Talangbayan H, Denburg S, Carbotte R, Denburg JA. Behavior and immune status of MRL mice in the postweaning period. Brain, Behavior, and Immunity. 8: 1-13. PMID 8003767 DOI: 10.1006/brbi.1994.1001  1
1994 Sakić B, Szechtman H, Talangbayan H, Denburg SD, Carbotte RM, Denburg JA. Disturbed emotionality in autoimmune MRL-lpr mice. Physiology & Behavior. 56: 609-17. PMID 7972416 DOI: 10.1016/0031-9384(94)90309-3  1
1994 Szechtman H, Dai H, Mustafa S, Einat H, Sullivan RM. Effects of dose and interdose interval on locomotor sensitization to the dopamine agonist quinpirole. Pharmacology, Biochemistry, and Behavior. 48: 921-8. PMID 7972297 DOI: 10.1016/0091-3057(94)90201-1  1
1994 Szechtman H, Talangbayan H, Canaran G, Dai H, Eilam D. Dynamics of behavioral sensitization induced by the dopamine agonist quinpirole and a proposed central energy control mechanism. Psychopharmacology. 115: 95-104. PMID 7862919 DOI: 10.1007/BF02244885  1
1993 Szechtman H, Talangbayan H, Eilam D. Environmental and behavioral components of sensitization induced by the dopamine agonist quinpirole. Behavioural Pharmacology. 4: 405-410. PMID 11224209  1
1993 Einat H, Szechtman H. Environmental modulation of both locomotor response and locomotor sensitization to the dopamine agonist quinpirole. Behavioural Pharmacology. 4: 399-403. PMID 11224208  1
1993 Sullivan RM, Parker BA, Szechtman H. Role of the corpus callosum in expression of behavioral asymmetries induced by a unilateral dopamine lesion of the substantia nigra in the rat. Brain Research. 609: 347-50. PMID 8508317 DOI: 10.1016/0006-8993(93)90895-T  1
1993 Sakić B, Szechtman H, Denburg S, Carbotte R, Denburg JA. Spatial learning during the course of autoimmune disease in MRL mice. Behavioural Brain Research. 54: 57-66. PMID 8504012 DOI: 10.1016/0166-4328(93)90048-U  1
1993 Heritch AJ, Szechtman H, Kaplan RD, Franco S, Szechtman B, Nahmias C, Garnett ES. Auditory hallucinations in schizophrenic patients [13] American Journal of Psychiatry. 150: 1275-1276. PMID 8328587  1
1993 Kaplan RD, Szechtman H, Franco S, Szechtman B, Nahmias C, Garnett ES, List S, Cleghorn JM. Three clinical syndromes of schizophrenia in untreated subjects: relation to brain glucose activity measured by positron emission tomography (PET). Schizophrenia Research. 11: 47-54. PMID 8297804 DOI: 10.1016/0920-9964(93)90037-J  1
1993 Sakić B, Szechtman H, Denburg S, Carbotte R, Denburg JA. Brain-reactive antibodies and behavior of autoimmune MRL-lpr mice. Physiology & Behavior. 54: 1025-9. PMID 8248368 DOI: 10.1016/0031-9384(93)90319-B  1
1993 Eilam D, Szechtman H, Faigon M, Dubovik V, Feldon J, Michaelson DM. Disintegration of the spatial organization of behavior in experimental autoimmune dementia. Neuroscience. 56: 83-91. PMID 8232920 DOI: 10.1016/0306-4522(93)90564-V  1
1993 Einat H, Szechtman H. Longlasting consequences of chronic treatment with the dopamine agonist quinpirole for the undrugged behavior of rats. Behavioural Brain Research. 54: 35-41. PMID 8099289 DOI: 10.1016/0166-4328(93)90046-S  1
1992 Eilam D, Talangbayan H, Canaran G, Szechtman H. Dopaminergic control of locomotion, mouthing, snout contact, and grooming: opposing roles of D1 and D2 receptors Psychopharmacology. 106: 447-454. PMID 1533720 DOI: 10.1007/BF02244813  1
1992 Sakić B, Szechtman H, Keffer M, Talangbayan H, Stead R, Denburg JA. A behavioral profile of autoimmune lupus-prone MRL mice. Brain, Behavior, and Immunity. 6: 265-85. PMID 1392101 DOI: 10.1016/0889-1591(92)90048-S  1
1992 Sullivan R, Dogaru C, Szechtman H. Constriction of environmental space and the behavioral response to the dopamine agonist quinpirole. Pharmacology, Biochemistry, and Behavior. 43: 1217-9. PMID 1361993 DOI: 10.1016/0091-3057(92)90505-A  1
1992 Cleghorn JM, Franco S, Szechtman B, Kaplan RD, Szechtman H, Brown GM, Nahmias C, Garnett ES. Toward a brain map of auditory hallucinations. The American Journal of Psychiatry. 149: 1062-9. PMID 1353314  1
1992 Eilam D, Szechtman H, Spear LP. Quinpirole alters quadruped activity in rats from the second postnatal week. Developmental Psychobiology. 25: 275-89. PMID 1352505 DOI: 10.1002/dev.420250405  1
1991 Cleghorn JM, Szechtman H, Garnett ES, Nahmias C, Brown GM, Kaplan RD, Szechtman B, Franco S. Apomorphine effects on brain metabolism in neuroleptic-naive schizophrenic patients Psychiatry Research. 40: 135-153. PMID 1763143  1
1991 Eilam D, Clements KVA, Szechtman H. Differential effects of D1 and D2 dopamine agonists on stereotyped locomotion in rats Behavioural Brain Research. 45: 117-124. PMID 1686397 DOI: 10.1016/S0166-4328(05)80077-4  1
1991 Cleghorn JM, Szechtman H, Garnett ES, Brown GM, Nahmias C, Szechtman B, Kaplan R, Franco S. 17. Neuroleptic effects on regional brain metabolism in first episode schizophrenics Schizophrenia Research. 5: 208-209. PMID 1684720 DOI: 10.1016/0920-9964(91)90077-5  1
1991 Cleghorn JM, Kaplan RD, Szechtman B, Szechtman H, Brown GM, Franco S. Substance abuse and schizophrenia: Effect on symptoms but not on neurocognitive function Journal of Clinical Psychiatry. 52: 26-30. PMID 1671032  1
1990 Ziegler MG, Szechtman H. Relation between motor asymmetry and direction of rotational behaviour under amphetamine and apomorphine in rats with unilateral degeneration of the nigrostriatal dopamine system. Behavioural Brain Research. 39: 123-33. PMID 2390196 DOI: 10.1016/0166-4328(90)90099-Z  1
1990 Gleghorn JM, Garnett ES, Nahmias C, Brown GM, Kaplan RD, Szechtman H, Szechtman B, Franco S, Dermer SW, Cook P. Regional brain metabolism during auditory hallucinations in chronic schizophrenia British Journal of Psychiatry. 157: 562-570. PMID 2131139  1
1990 Cleghorn JM, Kaplan RD, Szechtman B, Szechtman H, Brown GM. Neuroleptic drug effects on cognitive function in schizophrenia Schizophrenia Research. 3: 211-219. PMID 1980613 DOI: 10.1016/0920-9964(90)90038-9  1
1990 Eilam D, Szechtman H. Dosing regimen differentiates sensitization of locomotion and mouthing to D2 agonist quinpirole Pharmacology, Biochemistry and Behavior. 36: 989-991. PMID 1977180 DOI: 10.1016/0091-3057(90)90111-T  1
1989 Cleghorn JM, Kaplan RD, Nahmias C, Garnett ES, Szechtman H, Szechtman B. Inferior Parietal Region Implicated in Neurocognitive Impairment in Schizophrenia Archives of General Psychiatry. 46: 758-759. PMID 2787624 DOI: 10.1001/archpsyc.1989.01810080088016  1
1989 Cleghorn JM, Garnett ES, Nahmias C, Firnau G, Brown GM, Kaplan R, Szechtman H, Szechtman B. Increased frontal and reduced parietal glucose metabolism in acute untreated schizophrenia Psychiatry Research. 28: 119-133. PMID 2787515 DOI: 10.1016/0165-1781(89)90040-1  1
1989 Eilam D, Szechtman H. Biphasic effect of D-2 agonist quinpirole on locomotion and movements European Journal of Pharmacology. 161: 151-157. PMID 2566488 DOI: 10.1016/0014-2999(89)90837-6  1
1989 Eilam D, Golani I, Szechtman H. D2-agonist quinpirole induces perseveration of routes and hyperactivity but no perseveration of movements. Brain Research. 490: 255-67. PMID 2527582 DOI: 10.1016/0006-8993(89)90243-6  1
1988 Brown GM, Cleghorn JM, Kaplan RD, Szechtman H, Brown PJ, Szechtman B, Mitton J. Longitudinal growth hormone studies in schizophrenia Psychiatry Research. 24: 123-136. PMID 3406233 DOI: 10.1016/0165-1781(88)90055-8  1
1988 Szechtman H, Cleghorn JM, Brown GM, Kaplan RD, Franco S, Rosenthal K. Sensitization and tolerance to apomorphine in men: Yawning, growth hormone, nausea, and hyperthermia Psychiatry Research. 23: 245-255. PMID 3387500 DOI: 10.1016/0165-1781(88)90015-7  1
1988 Szechtman H. Effect of the dopamine receptor agonist apomorphine on sensory input Naunyn-Schmiedeberg's Archives of Pharmacology. 338: 489-496. PMID 3244390 DOI: 10.1007/BF00179319  1
1988 Brown PJ, Cleghorn JM, Brown GM, Kaplan RD, Mitton J, Szechtman H, Szechtman B. Seasonal variations in prolactin levels in Schizophrenia Psychiatry Research. 25: 157-162. PMID 3174903 DOI: 10.1016/0165-1781(88)90046-7  1
1988 Ziegler M, Szechtman H. Differences in the Behavioral Profile of Circling Under Amphetamine and Apomorphine in Rats With Unilateral Lesions of the Substantia Nigra Behavioral Neuroscience. 102: 276-288. PMID 3130074 DOI: 10.1037/0735-7044.102.2.276  1
1988 Szechtman H, Nahmias C, Garnett ES, Brown GM, Kaplan RD, Cleghorn JM, Firnau G. Effect of Neuroleptics on Altered Cerebral Glucose Metabolism in Schizophrenia Archives of General Psychiatry. 45: 523-532. PMID 2897836 DOI: 10.1001/archpsyc.1988.01800300019002  1
1988 Szechtman H, Eilam D, Teitelbaum P, Golani I. A different look at measurement and interpretation of drug-induced stereotyped behavior Psychobiology. 16: 164-173. DOI: 10.3758/BF03333121  1
1987 Vanderwolf CH, Szechtman H. Electrophysiological correlates of stereotyped sniffing in rats injected with apomorphine. Pharmacology, Biochemistry, and Behavior. 26: 299-304. PMID 3575354 DOI: 10.1016/0091-3057(87)90122-5  1
1986 Pisa M, Szechtman H. Lateralized and compulsive exteroceptive orientation in rats treated with apomorphine Neuroscience Letters. 64: 41-46. PMID 3960386 DOI: 10.1016/0304-3940(86)90660-9  1
1986 Szechtman H. Behavior performed at onset of drug action and apomorphine stereotypy European Journal of Pharmacology. 121: 49-56. PMID 3956573 DOI: 10.1016/0014-2999(86)90391-2  1
1986 Szechtman H, Pisa M. Postural asymmetry and lateralized rotation in normal rats administered apomorphine Pharmacology, Biochemistry and Behavior. 25: 689-691. PMID 3774835 DOI: 10.1016/0091-3057(86)90160-7  1
1986 Szechtman H. Effects of pretreatment with naloxone on behaviours induced by a small dose of apomorphine Pharmacology, Biochemistry and Behavior. 24: 1779-1783. PMID 3737643 DOI: 10.1016/0091-3057(86)90520-4  1
1985 Pisa M, Szechtman H. Lateralizing effects of apomorphine on taxis, postural support and rotation in rats Progress in Neuropsychopharmacology and Biological Psychiatry. 9: 525-531. PMID 4089183 DOI: 10.1016/0278-5846(85)90012-0  1
1985 Szechtman H, Adler NT, Komisaruk BR. Mating induces pupillary dilatation in female rats: role of pelvic nerve. Physiology & Behavior. 35: 295-301. PMID 4070399 DOI: 10.1016/0031-9384(85)90352-X  1
1985 Szechtman H, Ornstein K, Teitelbaum P, Golani I. The morphogenesis of stereotyped behavior induced by the dopamine receptor agonist apomorphine in the laboratory rat. Neuroscience. 14: 783-98. PMID 2986045 DOI: 10.1016/0306-4522(85)90143-5  1
1984 Szechtman H. Timing of yawns induced by a small dose of apomorphine and its alteration by naloxone Progress in Neuropsychopharmacology and Biological Psychiatry. 8: 743-746. PMID 6531446 DOI: 10.1016/0278-5846(84)90050-2  1
1983 Szechtman H. Peripheral sensory input directs apomorphine-induced circling in rats Brain Research. 264: 332-335. PMID 6850305 DOI: 10.1016/0006-8993(83)90836-3  1
1982 Szechtman H, Ornstein K, Teitelbaum P, Golani I. Snout contact fixation, climbing and gnawing during apomorphine stereotypy in rats from two substrains. European Journal of Pharmacology. 80: 385-92. PMID 7201932 DOI: 10.1016/0014-2999(82)90084-X  1
1982 Burns TG, Szechtman H, Brown GM, Snieckus V. Behavioral effects of 5-hydroxy-N-acetyltryptophan, a putative synthetic precursor of N-acetylserotonin Progress in Neuropsychopharmacology and Biological Psychiatry. 6: 359-363. PMID 6984517 DOI: 10.1016/S0278-5846(82)80107-3  1
1981 Kalcheim C, Szechtman H, Koch Y. Bisexual behavior in male rats treated neonatally with antibodies to luteinizing hormone-releasing hormone. Journal of Comparative and Physiological Psychology. 95: 36-44. PMID 7012206 DOI: 10.1037/h0077762  1
1981 Szechtman H, Hershkowitz M, Simantov R. Sexual behavior decreases pain sensitivity and stimulates endogenous opioids in male rats European Journal of Pharmacology. 70: 279-285. PMID 6262094 DOI: 10.1016/0014-2999(81)90161-8  1
1981 Szechtman H, Ornstein K, Teitelbaum P, Golani I. Apomorphine stereotypy: A multidimensional process of regression to a simpler behavioural state Progress in Neuro-Psychopharmacology. 5: 314-315.  1
1980 Semba K, Szechtman H, Komisaruk BR. Synchrony among rhythmical facial tremor, neocortical 'alpha' waves, and thalamic non-sensory neuronal bursts in intact awake rats. Brain Research. 195: 281-98. PMID 7397502 DOI: 10.1016/0006-8993(80)90065-7  1
1980 Szechtman H, Hall WG. Ontogeny of oral behavior induced by tail pinch and electrical stimulation of the tail in rats. Journal of Comparative and Physiological Psychology. 94: 436-45. PMID 7391280 DOI: 10.1037/h0077683  1
1980 Szechtman H. Redirected oral behavior in rats induced by tail-pinch and electrical stimulation of the tail Physiology and Behavior. 24: 57-64. PMID 7384251 DOI: 10.1016/0031-9384(80)90014-1  1
1980 Simantov R, Szechtman H, Hershkowitz M. Pituitary endorphins in female rats Israel Journal of Medical Sciences. 16: 878.  1
1979 Szechtman H, Levy I. An automatic device for delivering "tail-pinch" stimulation to freely moving rats Physiology and Behavior. 23: 197-199. PMID 515211 DOI: 10.1016/0031-9384(79)90144-6  1
1979 Hershkowitz M, Szechtman H. Pretreatment with δ1-tetrahydrocannabinol and psychoactive drugs: Effects on uptake of biogenic amines and on behavior European Journal of Pharmacology. 59: 267-276. PMID 230975 DOI: 10.1016/0014-2999(79)90290-5  1
1978 Szechtman H, Caggiula AR, Wulkan D. Preoptic knife cuts and sexual behavior in male rats. Brain Research. 150: 569-95. PMID 307976 DOI: 10.1016/0006-8993(78)90821-1  1
1977 Szechtman H, Siegel HI, Rosemblatt JS, Komisaruk BR. Tail-pinch facilitates onset of maternal behavior in rats. Physiology & Behavior. 19: 807-9. PMID 609620 DOI: 10.1016/0031-9384(77)90319-5  1
1976 Antelman SM, Szechtman H, Chin P, Fisher AE. Inhibition of tyrosine hydroxylase but not dopamine-beta-hydroxylase facilitates the action of behaviourally ineffective doses of neuroleptics. The Journal of Pharmacy and Pharmacology. 28: 66-8. PMID 6656  1
1975 Antelman SM, Szechtman H, Chin P, Fisher AE. Tail pinch-induced eating, gnawing and licking behavior in rats: dependence on the nigrostriatal dopamine system. Brain Research. 99: 319-37. PMID 1182545 DOI: 10.1016/0006-8993(75)90032-3  1
1975 Antelman SM, Szechtman H. Tail pinch induces eating in sated rats which appears to depend on nigrostriatal dopamine Science. 189: 731-733. PMID 1154024  1
1974 Szechtman H, Lambrou PJ, Caggiula AR, Redgate ES. Plasma corticosterone levels during sexual behavior in male rats. Hormones and Behavior. 5: 191-200. PMID 4847187 DOI: 10.1016/0018-506X(74)90043-9  1
1974 Redgate ES, Szechtman H, Fahringer EE. The effect of plasma cortisol concentration on the pituitary adrenal response elicited by electrical stimulation of the infundibular area of the awake unrestrained cat Hormone Research. 5: 173-181. PMID 4366050  1
1972 Caggiula AR, Szechtman H. Hypothalamic stimulation: a biphasic influence on copulation of the male rat. Behavioral Biology. 7: 591-8. PMID 5050144 DOI: 10.1016/S0091-6773(72)80221-9  1
Show low-probability matches.